Richard Maroun Buys 38,040 Shares of WHWK
Insider Richard Maroun purchased 38,040 shares of WHWK on June 12, 2026.
Key Points
- Richard Maroun purchased 38,040 shares of WHWK on June 12, 2026, at an unspecified price.
- Shares of WHWK traded near $4.16, with several institutional investors holding significant positions.
- Analysts from Citizens and Jones Trading initiated coverage with 'buy' ratings and targets of $8 and $7, respectively.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Richard Maroun, a notable insider, purchased 38,040 shares of WHWK on June 12, 2026. The transaction details, such as the price per share, weren't disclosed. However, this move suggests a level of confidence in the company's prospects.
Other Institutional Activity in WHWK
Several institutional investors maintain significant positions in WHWK. QVT Financial LP holds 4,615,709 shares valued at about $15.9 million. OrbiMed Advisors LLC has 4,166,000 shares worth approximately $14.4 million. Suvretta Capital Management, LLC holds 3,700,000 shares, valued at $12.8 million. Acuta Capital Partners, LLC and Avoro Capital Advisors LLC hold 3,410,402 and 2,849,402 shares, valued at $11.8 million and $9.8 million, respectively.
Whitehawk Therapeutics, Inc. Stock Down 10.0%
Shares of WHWK are trading around $4.16. The stock's performance and valuation metrics were not detailed in the available data, but it remains a point of interest for several institutional investors.
$WHWK stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Whitehawk Therapeutics, Inc.
On June 12, 2026, several insiders, including Castelein Caley, Desai Neil, Reeve Emma, Maroun Richard, Zhao Baiteng, and Aghazadeh Behzad, each bought 38,040 shares of WHWK. These transactions were not part of a pre-planned trading program, indicating spontaneous investments by these insiders.
Analysts Set New Price Targets
On April 16, 2026, Citizens initiated coverage on WHWK with a 'buy' rating and set a price target of $8. Previously, on December 22, 2025, Jones Trading also initiated coverage with a 'buy' rating and a $7 price target. These ratings reflect positive sentiment from analysts about WHWK's potential.
About WHWK
WHWK operates in a sector that wasn't specified in the provided data. The company is involved in business activities that attract significant insider and institutional interest, suggesting potential growth or strategic developments.
Bottom Line
Richard Maroun's purchase of 38,040 shares of WHWK on June 12, 2026, is a clear indication of insider confidence. While the stock trades at $4.16, several institutional investors maintain substantial holdings. Analyst coverage with 'buy' ratings further suggests optimism about the company's future.
Get Whitehawk Therapeutics, Inc. alerts
New 13F filings, insider trades, and analyst moves on $WHWK, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.